echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eight tables to help you figure out the classification of anticancer drugs

    Eight tables to help you figure out the classification of anticancer drugs

    • Last Update: 2022-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    At present, antitumor drugs are classified according to their drug sources and mechanism of action, which is of practical significance for grasping the characteristics of drugs and designing combined drug regimens


    At present, antitumor drugs are classified according to their drug sources and mechanism of action, which is of practical significance for grasping the characteristics of drugs and designing combined drug regimens


    1.


    1.


    In recent years, the progress of cytotoxic drugs is limited.


    In recent years, the progress of cytotoxic drugs is limited.


     

     

    2.


    2.


    Currently commonly used targeted drugs include anti-EGFR, ALK, MET and other inhibitors, as well as multi-target multi-kinase inhibitors


    Currently commonly used targeted drugs include anti-EGFR, ALK, MET and other inhibitors, as well as multi-target multi-kinase inhibitors


     

     

    3.


    3.


    Monoclonal antibodies are antibodies directed against a specific epitope and also have a targeting effect


    Monoclonal antibodies are antibodies directed against a specific epitope and also have a targeting effect


     

     

     

    4.


    4.


    In tumor immunotherapy, immune checkpoint inhibitors are the most in-depth and extensive research, which is the second time to change the tumor treatment landscape after targeted therapy
    .
    In addition to the common inhibition of PD-1, PD-L1, and CTLA-4, research on dual-antibody drugs is also underway
    .

    In tumor immunotherapy, immune checkpoint inhibitors are the most in-depth and extensive research, which is the second time to change the tumor treatment landscape after targeted therapy
    .
    In addition to the common inhibition of PD-1, PD-L1, and CTLA-4, research on dual-antibody drugs is also underway
    .


     

     

     

     

    5.
    Hormones

    5.
    Hormones 5.
    Hormones

     

    Hormonal drugs are a common treatment component for sex hormone-affected tumors such as breast and prostate cancer
    .
    Commonly used hormonal drugs are summarized in the table below
    .

    Hormonal drugs are a common treatment component for sex hormone-affected tumors such as breast and prostate cancer
    .
    Commonly used hormonal drugs are summarized in the table below
    .

     

     

     

    6.
    Antibody-conjugated drugs

    6.
    Antibody Conjugates 6.
    Antibody Conjugates

     

    Antibody-Drug Conjugate (ADC) is another hot spot in current drug research
    .
    ADCs couple cytotoxic drugs to monoclonal antibodies through linkers.
    Using the characteristics of antigen-antibody specific binding, the cytotoxic drugs can be specifically delivered to the tumor to play a killing effect
    .
    A number of ADCs are already on the market
    .
    In addition, drugs targeting targets such as Trop2 and CD79 are also in clinical trials
    .

    Antibody-Drug Conjugate (ADC) is another hot spot in current drug research
    .
    ADCs couple cytotoxic drugs to monoclonal antibodies through linkers.
    Using the characteristics of antigen-antibody specific binding, the cytotoxic drugs can be specifically delivered to the tumor to play a killing effect
    .
    A number of ADCs are already on the market
    .
    In addition, drugs targeting targets such as Trop2 and CD79 are also in clinical trials
    .

     

     ​

     

    7.
    Other

    Seven, other Seven, other

     

    In addition, drugs that are difficult to be classified, such as biological response modifiers, differentiation inducers, and tumor vaccines, are included in other categories
    .

    In addition, drugs that are difficult to be classified, such as biological response modifiers, differentiation inducers, and tumor vaccines, are included in other categories
    .

     

     

     

    8.
    Auxiliary drugs

    8.
    Auxiliary drugs 8.
    Auxiliary drugs

     

    Tumor adjuvant drugs are also an important part of anti-tumor therapy, helping to reduce adverse events of anti-tumor therapy and relieve symptoms of patients
    .

    Tumor adjuvant drugs are also an important part of anti-tumor therapy, helping to reduce adverse events of anti-tumor therapy and relieve symptoms of patients
    .

     

     

    Source: Yijia Classroom left a

    message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.